Corporate calendar for Adicet Bio, Inc. (ACET): upcoming earnings dates, dividend ex-dates and payment dates, stock splits, shareholder meetings and conference calls. Plan your positions around the key catalysts.
Adicet Bio, Inc. is a biotechnology firm dedicated to pioneering allogeneic gamma delta T cell therapies, aiming to treat cancer and various other diseases. The company’s strategy involves engineering gamma delta T cells with chimeric antigen receptors (CARs) and T cell receptor-like antibodies.
Upcoming Earnings
| Date | EPS Est. | Revenue Est. |
|---|---|---|
| 2026-09-14 | $-0.05 | $8M |
| 2026-09-14 | ||
| 2026-09-14 | $0.06 | $3M |
| 2026-09-14 | $36.39 | $67M |
| 2026-09-14 | $-0.03 | $278M |
| 2026-09-14 | $898M |
Dividend History
| Date | Amount | Yield |
|---|---|---|
| 2018-09-21 | $0.0001 | 0.00% |
| 2018-06-07 | $0.0001 | 0.00% |
| 2018-03-08 | $0.0006 | 0.03% |
| 2017-12-15 | $0.0006 | 0.03% |
| 2017-09-07 | $0.0006 | 0.03% |
| 2017-06-07 | $0.0006 | 0.03% |
| 2017-03-08 | $0.0006 | 0.03% |
| 2016-12-08 | $0.0006 | 0.03% |
| 2016-09-07 | $0.0006 | 0.03% |
| 2016-06-07 | $0.0005 | 0.02% |
Price
| Price | $9.05 |
| Market Cap | $85M |
| Exchange | NASDAQ |
| Country | US |
Analyst Consensus
| Strong Buy | 0 |
| Buy | 9 |
| Hold | 3 |
| Sell | 0 |
| Strong Sell | 0 |
| Total analysts | 12 |
| Avg rating (1-5) | 0.75 |
Related companies: ACRV · ADAG · CRVO · GANX · HOWL · IMUX · IOBT
Explore sector: Healthcare · Biotechnology
More sections of ACET: Overview · Financials · Valuation · Statistics · Estimates · Technical · Ownership · News
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks